Merck MRK
NYSE MRK
$144.99 -2.54 (-1.72%)
As of: Sep 10, 2026 · 2:41 PM EDT

Merck (MRK) Exchange Rate Effect (2009 - 2026)

Merck's (MRK) quarterly Exchange Rate Effect came in at -$37.0 million in Q2 2026, down 109.89% year-over-year from $374.0 million in Q2 2025, and down 94.74% quarter-over-quarter from -$19.0 million in Q1 2026.

Analysis

Merck (MRK) Exchange Rate Effect (2009 - 2026) Analysis & Trends

Merck (MRK) has reported Exchange Rate Effect for 18 consecutive years, with -$37.0 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Exchange Rate Effect fell 109.89% year-over-year to -$37.0 million in Q2 2026; TTM through Jun 2026 was -$23.0 million, a 105.03% decrease from a year earlier, with the FY2025 full-year figure at $563.0 million, up 292.15% from the prior year.
  • Exchange Rate Effect was -$37.0 million for Q2 2026 at Merck, down from -$19.0 million in the prior quarter.
  • Over five years, Exchange Rate Effect peaked at $374.0 million in Q2 2025 and troughed at -$412.0 million in Q3 2022.
  • A 5-year average of -$9.6 million and a median of -$28.0 million in 2026 frame the typical range for Exchange Rate Effect.
  • The widest YoY moves for Exchange Rate Effect: up 638.24% in 2022, down 795.65% in 2022.
  • Over 5 years, Exchange Rate Effect stood at $366.0 million in 2022, then tumbled by 49.18% to $186.0 million in 2023, then tumbled by 297.31% to -$367.0 million in 2024, then soared by 106.27% to $23.0 million in 2025, then slumped by 260.87% to -$37.0 million in 2026.
  • The last three Exchange Rate Effect figures came in at -$37.0 million (Q2 2026), -$19.0 million (Q1 2026), and $23.0 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Exchange Rate Effect (Qtr)
1 Johnson & Johnson 643.20 Bn 622.44 Bn 17.26 Bn 5.00 Mn
2 AbbVie 448.14 Bn 441.57 Bn 12.70 Bn -7.00 Mn
3 Merck 358.13 Bn 350.98 Bn 12.21 Bn -37.00 Mn
4 Novartis Ag 267.81 Bn 260.12 Bn 11.24 Bn -18.00 Mn
5 Pfizer 156.55 Bn 144.85 Bn 10.94 Bn -4.00 Mn
6 Sanofi 52.17 Bn 44.78 Bn 10.79 Bn 11.62 Mn
7 Revolution Medicines 42.92 Bn 42.92 Bn - -
8 Incyte 24.72 Bn 20.19 Bn 1.57 Bn -84,000.00
9 United Therapeutics 21.55 Bn 18.89 Bn 683.80 Mn -
10 Neurocrine Biosciences 15.83 Bn 15.44 Bn 935.80 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -37.00 Mn
Mar 31, 2026 -19.00 Mn
Dec 31, 2025 23.00 Mn
Sep 30, 2025 10.00 Mn
Jun 30, 2025 374.00 Mn
Mar 31, 2025 156.00 Mn
Dec 31, 2024 -367.00 Mn
Sep 30, 2024 294.00 Mn
Jun 30, 2024 -82.00 Mn
Mar 31, 2024 -138.00 Mn
Dec 31, 2023 186.00 Mn
Sep 30, 2023 -157.00 Mn
Jun 30, 2023 -93.00 Mn
Mar 31, 2023 87.00 Mn
Dec 31, 2022 366.00 Mn
Sep 30, 2022 -412.00 Mn
Jun 30, 2022 -309.00 Mn
Mar 31, 2022 -55.00 Mn
Dec 31, 2021 -68.00 Mn
Sep 30, 2021 -46.00 Mn